Arkolith/Insider Trading/KRBP/Form 4

Chiriva Internati Maurizio

CHIEF EXECUTIVE OFFICER, DirectorKiromic Biopharma, Inc. (KRBP) · full profile →Form 4 · filed Sep 10, 2021
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2021Buy(P)3K$3.70$10K1.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-114510) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML